| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Amoon Growth Fund Limited Partnership last filed a Form 4 in October 2023, as 10% Owner at SEER. The filings on record cover 2 companies.
At the last filing, the largest reported position was 810,961 shares of SEER. The SEER filings lean toward selling, a net 110,527 shares.
Amoon Growth Fund Limited Partnership has 3 Form 4 filings on record from December 2020 to October 2023, across 2 companies: 10% Owner at Ayala Pharmaceuticals (ADXS), 2023; 10% Owner at Seer (SEER), 2020–2021.
The 8 reported transactions were 3 open-market purchases, 2 open-market sales, 2 conversions and 1 other transaction.
Counted by filing, the open-market trades come to 1 purchase worth about $16.9M and 1 sale worth about $30.0M.
The only open-market purchase was 889,473 shares of SEER at an average $19.00 on December 9, 2020, about $16.9M.
The only open-market sale was 1,000,000 shares of SEER at an average $30.00 on June 9, 2021, about $30.0M. Twelve months later SEER was down 75%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.